GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

9 Months Ended

Jul. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill balances and movements for each reportable segments during the period

The following table presents goodwill balances and the movements for each of our reportable segments during the nine months ended July 31, 2016:

	Life Sciences and Applied Markets		Diagnostics and Genomics		Agilent CrossLab		Total
	(in millions)
Goodwill as of October 31, 2015	$	650	$	1,234	$	482	$	2,366
Foreign currency translation impact	5		14		3		22
Goodwill arising from acquisitions	137		—		—		137
Goodwill as of July 31, 2016:	$	792	$	1,248	$	485	$	2,525

Components of other intangibles during the period

The components of other intangibles as of July 31, 2016 and October 31, 2015 are shown in the table below:

	Purchased Other Intangible Assets
	Gross Carrying Amount		Accumulated Amortization		Net Book Value
	(in millions)
As of October 31, 2015:
Purchased technology	$	746	$	476	$	270
Trademark/Tradename	141		50		91
Customer relationships	230		168		62
Total amortizable intangible assets	1,117		694		423
In-Process R&D	22		—		22
Total	$	1,139	$	694	$	445
As of July 31, 2016:
Purchased technology	$	830	$	553	$	277
Backlog	1		1		—
Trademark/Tradename	151		59		92
Customer relationships	263		208		55
Total amortizable intangible assets	1,245		821		424
In-Process R&D	18		—		18
Total	$	1,263	$	821	$	442

Schedule of estimated future amortization expense of finite-lived intangible assets

Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2016 and for each of the five succeeding fiscal years and thereafter is estimated below:

Estimated future amortization expense:
(in millions)
Remainder of 2016	$	32
2017	$	112
2018	$	82
2019	$	58
2020	$	48
2021	$	35
Thereafter	$	57